The global market for Good Manufacturing Practice (GMP) Release Testing was estimated to be worth US$ 1530 million in 2023 and is forecast to a readjusted size of US$ 2418.9 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030
North American market for Good Manufacturing Practice (GMP) Release Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Good Manufacturing Practice (GMP) Release Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Good Manufacturing Practice (GMP) Release Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Good Manufacturing Practice (GMP) Release Testing include Intertek, Eurofins, SGS, Almac, Excite Pharma Services, TUV SUD, Charles River Laboratories, Bio-Rad and Element, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Good Manufacturing Practice (GMP) Release Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Good Manufacturing Practice (GMP) Release Testing by region & country, by Type, and by Application.
The Good Manufacturing Practice (GMP) Release Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Good Manufacturing Practice (GMP) Release Testing.
麻豆原创 Segmentation
By Company
Intertek
Eurofins
SGS
Almac
Excite Pharma Services
TUV SUD
Charles River Laboratories
Bio-Rad
Element
Merck
Boston Analytical
ALS Life Sciences
Reading Scientific Services
Lucideon
Tepnel Pharma Services
Nutrasource
Vetter Pharma
WESSLING
Sotax
Pace Analytical
Tergus Pharma
Symbiosis
Broughton Group
Segment by Type:
Chemical Testing
Physical Testing
Segment by Application
Big Pharmaceutical Companies
Small and Medium Pharmaceutical Companies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Good Manufacturing Practice (GMP) Release Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Good Manufacturing Practice (GMP) Release Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Good Manufacturing Practice (GMP) Release Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Good Manufacturing Practice (GMP) Release Testing Product Introduction
1.2 Global Good Manufacturing Practice (GMP) Release Testing 麻豆原创 Size Forecast
1.3 Good Manufacturing Practice (GMP) Release Testing 麻豆原创 Trends & Drivers
1.3.1 Good Manufacturing Practice (GMP) Release Testing Industry Trends
1.3.2 Good Manufacturing Practice (GMP) Release Testing 麻豆原创 Drivers & Opportunity
1.3.3 Good Manufacturing Practice (GMP) Release Testing 麻豆原创 Challenges
1.3.4 Good Manufacturing Practice (GMP) Release Testing 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Good Manufacturing Practice (GMP) Release Testing Players Revenue Ranking (2023)
2.2 Global Good Manufacturing Practice (GMP) Release Testing Revenue by Company (2019-2024)
2.3 Key Companies Good Manufacturing Practice (GMP) Release Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Good Manufacturing Practice (GMP) Release Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Good Manufacturing Practice (GMP) Release Testing
2.6 Good Manufacturing Practice (GMP) Release Testing 麻豆原创 Competitive Analysis
2.6.1 Good Manufacturing Practice (GMP) Release Testing 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Good Manufacturing Practice (GMP) Release Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Good Manufacturing Practice (GMP) Release Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemical Testing
3.1.2 Physical Testing
3.2 Global Good Manufacturing Practice (GMP) Release Testing Sales Value by Type
3.2.1 Global Good Manufacturing Practice (GMP) Release Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Good Manufacturing Practice (GMP) Release Testing Sales Value, by Type (2019-2030)
3.2.3 Global Good Manufacturing Practice (GMP) Release Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Big Pharmaceutical Companies
4.1.2 Small and Medium Pharmaceutical Companies
4.2 Global Good Manufacturing Practice (GMP) Release Testing Sales Value by Application
4.2.1 Global Good Manufacturing Practice (GMP) Release Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Good Manufacturing Practice (GMP) Release Testing Sales Value, by Application (2019-2030)
4.2.3 Global Good Manufacturing Practice (GMP) Release Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Good Manufacturing Practice (GMP) Release Testing Sales Value by Region
5.1.1 Global Good Manufacturing Practice (GMP) Release Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Good Manufacturing Practice (GMP) Release Testing Sales Value by Region (2019-2024)
5.1.3 Global Good Manufacturing Practice (GMP) Release Testing Sales Value by Region (2025-2030)
5.1.4 Global Good Manufacturing Practice (GMP) Release Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
5.2.2 North America Good Manufacturing Practice (GMP) Release Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
5.3.2 Europe Good Manufacturing Practice (GMP) Release Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Good Manufacturing Practice (GMP) Release Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
5.5.2 South America Good Manufacturing Practice (GMP) Release Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Good Manufacturing Practice (GMP) Release Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Good Manufacturing Practice (GMP) Release Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Good Manufacturing Practice (GMP) Release Testing Sales Value
6.3 United States
6.3.1 United States Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
6.3.2 United States Good Manufacturing Practice (GMP) Release Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Good Manufacturing Practice (GMP) Release Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
6.4.2 Europe Good Manufacturing Practice (GMP) Release Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Good Manufacturing Practice (GMP) Release Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
6.5.2 China Good Manufacturing Practice (GMP) Release Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Good Manufacturing Practice (GMP) Release Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
6.6.2 Japan Good Manufacturing Practice (GMP) Release Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Good Manufacturing Practice (GMP) Release Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
6.7.2 South Korea Good Manufacturing Practice (GMP) Release Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Good Manufacturing Practice (GMP) Release Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Good Manufacturing Practice (GMP) Release Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Good Manufacturing Practice (GMP) Release Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Good Manufacturing Practice (GMP) Release Testing Sales Value, 2019-2030
6.9.2 India Good Manufacturing Practice (GMP) Release Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Good Manufacturing Practice (GMP) Release Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Intertek
7.1.1 Intertek Profile
7.1.2 Intertek Main Business
7.1.3 Intertek Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.1.4 Intertek Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Intertek Recent Developments
7.2 Eurofins
7.2.1 Eurofins Profile
7.2.2 Eurofins Main Business
7.2.3 Eurofins Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.2.4 Eurofins Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Eurofins Recent Developments
7.3 SGS
7.3.1 SGS Profile
7.3.2 SGS Main Business
7.3.3 SGS Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.3.4 SGS Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Almac Recent Developments
7.4 Almac
7.4.1 Almac Profile
7.4.2 Almac Main Business
7.4.3 Almac Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.4.4 Almac Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Almac Recent Developments
7.5 Excite Pharma Services
7.5.1 Excite Pharma Services Profile
7.5.2 Excite Pharma Services Main Business
7.5.3 Excite Pharma Services Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.5.4 Excite Pharma Services Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Excite Pharma Services Recent Developments
7.6 TUV SUD
7.6.1 TUV SUD Profile
7.6.2 TUV SUD Main Business
7.6.3 TUV SUD Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.6.4 TUV SUD Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.6.5 TUV SUD Recent Developments
7.7 Charles River Laboratories
7.7.1 Charles River Laboratories Profile
7.7.2 Charles River Laboratories Main Business
7.7.3 Charles River Laboratories Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.7.4 Charles River Laboratories Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Charles River Laboratories Recent Developments
7.8 Bio-Rad
7.8.1 Bio-Rad Profile
7.8.2 Bio-Rad Main Business
7.8.3 Bio-Rad Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.8.4 Bio-Rad Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Bio-Rad Recent Developments
7.9 Element
7.9.1 Element Profile
7.9.2 Element Main Business
7.9.3 Element Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.9.4 Element Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Element Recent Developments
7.10 Merck
7.10.1 Merck Profile
7.10.2 Merck Main Business
7.10.3 Merck Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.10.4 Merck Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Merck Recent Developments
7.11 Boston Analytical
7.11.1 Boston Analytical Profile
7.11.2 Boston Analytical Main Business
7.11.3 Boston Analytical Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.11.4 Boston Analytical Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Boston Analytical Recent Developments
7.12 ALS Life Sciences
7.12.1 ALS Life Sciences Profile
7.12.2 ALS Life Sciences Main Business
7.12.3 ALS Life Sciences Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.12.4 ALS Life Sciences Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.12.5 ALS Life Sciences Recent Developments
7.13 Reading Scientific Services
7.13.1 Reading Scientific Services Profile
7.13.2 Reading Scientific Services Main Business
7.13.3 Reading Scientific Services Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.13.4 Reading Scientific Services Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Reading Scientific Services Recent Developments
7.14 Lucideon
7.14.1 Lucideon Profile
7.14.2 Lucideon Main Business
7.14.3 Lucideon Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.14.4 Lucideon Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.14.5 Lucideon Recent Developments
7.15 Tepnel Pharma Services
7.15.1 Tepnel Pharma Services Profile
7.15.2 Tepnel Pharma Services Main Business
7.15.3 Tepnel Pharma Services Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.15.4 Tepnel Pharma Services Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.15.5 Tepnel Pharma Services Recent Developments
7.16 Nutrasource
7.16.1 Nutrasource Profile
7.16.2 Nutrasource Main Business
7.16.3 Nutrasource Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.16.4 Nutrasource Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.16.5 Nutrasource Recent Developments
7.17 Vetter Pharma
7.17.1 Vetter Pharma Profile
7.17.2 Vetter Pharma Main Business
7.17.3 Vetter Pharma Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.17.4 Vetter Pharma Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.17.5 Vetter Pharma Recent Developments
7.18 WESSLING
7.18.1 WESSLING Profile
7.18.2 WESSLING Main Business
7.18.3 WESSLING Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.18.4 WESSLING Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.18.5 WESSLING Recent Developments
7.19 Sotax
7.19.1 Sotax Profile
7.19.2 Sotax Main Business
7.19.3 Sotax Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.19.4 Sotax Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.19.5 Sotax Recent Developments
7.20 Pace Analytical
7.20.1 Pace Analytical Profile
7.20.2 Pace Analytical Main Business
7.20.3 Pace Analytical Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.20.4 Pace Analytical Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.20.5 Pace Analytical Recent Developments
7.21 Tergus Pharma
7.21.1 Tergus Pharma Profile
7.21.2 Tergus Pharma Main Business
7.21.3 Tergus Pharma Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.21.4 Tergus Pharma Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.21.5 Tergus Pharma Recent Developments
7.22 Symbiosis
7.22.1 Symbiosis Profile
7.22.2 Symbiosis Main Business
7.22.3 Symbiosis Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.22.4 Symbiosis Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.22.5 Symbiosis Recent Developments
7.23 Broughton Group
7.23.1 Broughton Group Profile
7.23.2 Broughton Group Main Business
7.23.3 Broughton Group Good Manufacturing Practice (GMP) Release Testing Products, Services and Solutions
7.23.4 Broughton Group Good Manufacturing Practice (GMP) Release Testing Revenue (US$ Million) & (2019-2024)
7.23.5 Broughton Group Recent Developments
8 Industry Chain Analysis
8.1 Good Manufacturing Practice (GMP) Release Testing Industrial Chain
8.2 Good Manufacturing Practice (GMP) Release Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Good Manufacturing Practice (GMP) Release Testing Sales Model
8.5.2 Sales Channel
8.5.3 Good Manufacturing Practice (GMP) Release Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Intertek
Eurofins
SGS
Almac
Excite Pharma Services
TUV SUD
Charles River Laboratories
Bio-Rad
Element
Merck
Boston Analytical
ALS Life Sciences
Reading Scientific Services
Lucideon
Tepnel Pharma Services
Nutrasource
Vetter Pharma
WESSLING
Sotax
Pace Analytical
Tergus Pharma
Symbiosis
Broughton Group
听
听
*If Applicable.